Elahere (mirvetuximab soravtansine) is an antibody-drug conjugate approved for platinum-resistant ovarian cancer with high FR-alpha levels, given by IV infusion every three weeks. Eye-related side effects are actually one of the most common issues with this treatment, including:
- Eye irritation
- Blurry vision
- Dry eyes
Show Full Answer
Elahere (mirvetuximab soravtansine) is an antibody-drug conjugate approved for platinum-resistant ovarian cancer with high FR-alpha levels, given by IV infusion every three weeks. Eye-related side effects are actually one of the most common issues with this treatment, including:
- Eye irritation
- Blurry vision
- Dry eyes
These eye side effects are well-known enough that many oncologists proactively prescribe steroid eye drops to help manage them. Regarding sunglasses specifically while using steroid eye drops on Elahere — this is a great question to bring directly to your oncologist or ophthalmologist, as they can give personalized guidance. Some patients are advised to wear UV-protective sunglasses to reduce light sensitivity and protect eyes during treatment. Your care team will know exactly what level of protection is right for your situation.
It may also be worth connecting with others on MyOvarianCancerTeam who have been through Elahere treatment, as firsthand experiences can be really valuable!
June 21
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
